Cargando…

Soluble Endoglin, Transforming Growth Factor-Beta 1 and Soluble Tumor Necrosis Factor Alpha Receptors in Different Clinical Manifestations of Preeclampsia

BACKGROUND: Despite intensive research, the etiopathogenesis of preeclampsia (PE) remains uncertain. Inflammatory and angiogenic factors are thought to play considerable roles in this disease. The objective of this study was to investigate the association between soluble endoglin (sEng), transformin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perucci, Luiza O., Gomes, Karina B., Freitas, Letícia G., Godoi, Lara C., Alpoim, Patrícia N., Pinheiro, Melina B., Miranda, Aline S., Teixeira, Antônio L., Dusse, Luci M., Sousa, Lirlândia P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4031102/ https://www.ncbi.nlm.nih.gov/pubmed/24851923 http://dx.doi.org/10.1371/journal.pone.0097632

Ejemplares similares

MMP-15 Is Upregulated in Preeclampsia, but Does Not Cleave Endoglin to Produce Soluble Endoglin
por: Kaitu’u-Lino, Tu’uhevaha J., et al.
Publicado: (2012)

Accuracy of Soluble Endoglin for Diagnosis of Preeclampsia and its Severity
por: Nikuei, Pooneh, et al.
Publicado: (2017)

Diagnostic and prognostic significance of serum soluble endoglin levels in preeclampsia and eclampsia
por: Sachan, Rekha, et al.
Publicado: (2016)

Placental Growth Factor, Soluble fms-Like Tyrosine Kinase 1, Soluble Endoglin, IL-6, and IL-16 as Biomarkers in Preeclampsia
por: Rădulescu, Carmen, et al.
Publicado: (2016)

Are Endocan Plasma Levels Altered in Preeclampsia?
por: Lopes, Ana Cristina dos Santos, et al.
Publicado: (2021)

Plasma Concentrations of Soluble Endoglin versus Standard Evaluation in Patients with Suspected Preeclampsia
por: Rana, Sarosh, et al.
Publicado: (2012)

The Role of Placental Growth Factor, Soluble Endoglin, and Uterine Artery Diastolic Notch to Predict the Early Onset of Preeclampsia
por: Lubis, Muara Panusunan, et al.
Publicado: (2019)

Maternal Serum Placental Growth Factor, Soluble Fms-Like Tyrosine Kinase-1, and Soluble Endoglin in Twin Gestations and the Risk of Preeclampsia—A Systematic Review
por: Kosinska-Kaczynska, Katarzyna, et al.
Publicado: (2020)

Role of soluble endoglin in BMP9 signaling
por: Lawera, Aleksandra, et al.
Publicado: (2019)

Pregnancy-Induced High Plasma Levels of Soluble Endoglin in Mice Lead to Preeclampsia Symptoms and Placental Abnormalities
por: Pérez-Roque, Lucía, et al.
Publicado: (2020)

Circulating soluble endoglin modifies the inflammatory response in mice
por: Ruiz-Remolina, Laura, et al.
Publicado: (2017)

Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction – implications as a preeclampsia treatment
por: Hannan, Natalie J., et al.
Publicado: (2017)

Soluble fms-Like Tyrosine Kinase 1 (sFlt1), Endoglin and Placental Growth Factor (PlGF) in Preeclampsia among High Risk Pregnancies
por: Powers, Robert W., et al.
Publicado: (2010)

Long term effects of soluble endoglin and mild hypercholesterolemia in mice hearts
por: Vitverova, Barbora, et al.
Publicado: (2020)

Loss of Akt activity increases circulating soluble endoglin release in preeclampsia: identification of inter-dependency between Akt-1 and heme oxygenase-1
por: Cudmore, Melissa J., et al.
Publicado: (2012)

High Soluble Endoglin Levels Do Not Induce Endothelial Dysfunction in Mouse Aorta
por: Nemeckova, Ivana, et al.
Publicado: (2015)

Generation of a Soluble Form of Human Endoglin Fused to Green Fluorescent Protein
por: Ruiz-Llorente, Lidia, et al.
Publicado: (2021)

Soluble Endoglin Stimulates Inflammatory and Angiogenic Responses in Microglia That Are Associated with Endothelial Dysfunction
por: Park, Eun S., et al.
Publicado: (2022)

Prognostic value of soluble endoglin in patients with septic shock and severe COVID-19
por: Tomášková, Veronika, et al.
Publicado: (2022)

Bioenergetic effects of hydrogen sulfide suppress soluble Flt-1 and soluble endoglin in cystathionine gamma-lyase compromised endothelial cells
por: Sanchez-Aranguren, Lissette Carolina, et al.
Publicado: (2020)

Circulating soluble fms-like tyrosine kinase-1, soluble endoglin and placental growth factor during pregnancy in normotensive women in KwaZulu-Natal, South Africa
por: Ogunlola, Muhammed, et al.
Publicado: (2019)

Chronic Venous Insufficiency: Transforming Growth Factor-β Isoforms and Soluble Endoglin Concentration in Different States of Wound Healing
por: Ligi, Daniela, et al.
Publicado: (2017)

Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patients
por: Blázquez-Medela, Ana M, et al.
Publicado: (2010)

High Soluble Endoglin Levels Affect Aortic Vascular Function during Mice Aging
por: Nejmanová, Iveta, et al.
Publicado: (2021)

Labetalol and soluble endoglin aggravate bile acid retention in mice with ethinylestradiol-induced cholestasis
por: Cristina Igreja Sá, Ivone, et al.
Publicado: (2023)

Low Plasma Levels of Soluble Endoglin and Cardiovascular Events in Patients Undergoing Coronary Angiography
por: Saita, Emi, et al.
Publicado: (2023)

Long-term observational study of renal outcome after preeclampsia: Role of soluble fms-like tyrosine kinase-1(sFlt-1)/ placental growth factor (PlGF) and endoglin
por: Thitivichienlert, Thanaphan, et al.
Publicado: (2022)

Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors
Publicado: (1992)

Transcription factor KLF6 upregulates expression of metalloprotease MMP14 and subsequent release of soluble endoglin during vascular injury
por: Gallardo-Vara, Eunate, et al.
Publicado: (2016)

High concentrations of soluble endoglin can inhibit BMP9 signaling in non-endothelial cells
por: Andersson-Rusch, Clara, et al.
Publicado: (2023)

The effect of capsaicin on circulating biomarkers, soluble tumor necrosis factor and soluble tumor necrosis factor-receptor-1 and -2 levels in vivo using lipopolysaccharide-treated mice
por: Ijiri, Yoshio, et al.
Publicado: (2014)

Low Soluble Syndecan-1 Precedes Preeclampsia
por: Gandley, Robin E., et al.
Publicado: (2016)

Annexin A1 Is Increased in the Plasma of Preeclamptic Women
por: Perucci, Luiza O., et al.
Publicado: (2015)

Endothelial Dysfunction in Severe Preeclampsia is Mediated by Soluble Factors, Rather than Extracellular Vesicles
por: O’Brien, Michelle, et al.
Publicado: (2017)

Soluble Endoglin Level Increase Occurs Prior to Development of Subclinical Structural Vascular Alterations in Diabetic Adolescents
por: Emeksiz, Hamdi Cihan, et al.
Publicado: (2016)

Vasoactive Soluble Endoglin: A Novel Biomarker Indicative of Reperfusion after Cerebral Large-Vessel Occlusion
por: Haarmann, Axel, et al.
Publicado: (2023)

Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis
por: Glossop, John R, et al.
Publicado: (2005)

Early effects of tumor necrosis factor inhibition on bone homeostasis after soluble tumor necrosis factor receptor use
por: Lim, Mie Jin, et al.
Publicado: (2014)

Interference of tumor necrosis factor inhibitor treatments on soluble tumor necrosis factor receptor 2 levels in rheumatoid arthritis
por: Yang, Nicole, et al.
Publicado: (2019)

DNA Methylation of Endoglin Pathway Genes in Pregnant Women With and Without Preeclampsia
por: Rietze, Allison H, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2l9hb0kkdc9ghcegc852rb4emn